Rheumatoid Arthritis Clinical Trials in New York

Showing 3341-3360 of 3,596 trials

COMPLETEDNA< 1 mile

Treatment for Women With Post-Traumatic Stress Disorder Related to Childhood Abuse

NCT00069381

This study will compare one- and two-component treatments in women with post-traumatic stress disorder (PTSD).

Stress Disorders, Post-Traumatic

NYU Langone Health144 participantsStarted Apr 2002

New York, New York, United States

COMPLETEDPhase 2< 1 mile

Study of a JAK3 Inhibitor for the Prevention of Acute Rejection in Kidney Transplant Patients

NCT00483756

A new immunosuppressive drug, based on the inhibition of an important enzyme in the immune system called JAK3, is being developed by Pfizer to prevent transplant rejection. In this research study, a JAK3 inhibitor or cyclosporine will be given to new kidney transplant patients for 12 months. Patients will be assigned to one of three treatment groups after receiving a kidney transplant. Two of the treatment groups will receive 2 different dosing regimens of the JAK3 inhibitor that will be taken by mouth. The third treatment group will be a standard-of-care control arm. Patients will continue to take the assigned study medication for 12 months as well as other standard transplant medications such as prednisone.

Kidney Transplantation

Pfizer338 participantsStarted Aug 2007

Little Rock, Arkansas, United States • Los Angeles, California, United States • Los Angeles, California, United States +66 more locations

Treatment for Women With Post-Traumatic Stress Disorder Related to Childhood Abuse

Study of a JAK3 Inhibitor for the Prevention of Acute Rejection in Kidney Transplant Patients

Rheumatoid Arthritis Trials in Other Cities

Egg Donor Recipient Characteristics Preferences

Anal Sphincter Prosthesis in Treating Patients Who Are Undergoing Surgery for Anal or Rectal Cancer

Study Comparing Sirolimus With Cyclosporine in a Calcineurin Inhibitor (CNI)-Free Regimen in Kidney Transplant Recipients

Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma

O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors

S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium

Open Label Continuation Study in Moderate to Severe Psoriasis

Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain

Does the Reduction of Total Body Iron Storage (TBIS) Alter Mortality in a Population of Patients With Advanced PVD?

Feasibility And Safety Study Of rhBMP-2/CPM For Hip Fractures

A Study of MAb-3F8 Plus Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus 13-cis-Retinoic Acid (RA) Plus GM-CSF in Primary Refractory Neuroblastoma Patients

Sofia RSV FIA Field Study

A Single Site Prospective, Non-randomized Study of Partial Breast Intracavitary Brachytherapy Devices to Evaluate Local Tumor Control, Cosmetic Outcome and Toxicities.

Safety of Immunosuppression Minimization in Children and Adolescents After Kidney Transplantation

Effects of Remodulin in Patients With Critical Limb Ischemia Following a Vein Bypass Graft

Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer

Validation Study of RA-INF-Dx, a Multigene Molecular Test Used to Predict Non-Response to INfliximab Therapy

Intrathecal Enzyme Replacement Therapy for Spinal Cord Compression in Mucopolysaccharidosis (MPS) I

Other Conditions in New York